Corbus Pharmaceuticals prices public offering of 4.325M shares at $19, expects ~$88.5M net proceeds

Corbus Pharmaceuticals Holdings, Inc.

Priced 4,325,000 shares of common stock at $19.00 per share; underwriters' option for additional 648,750 shares exercised in full.
Net proceeds expected to be approximately $88.5 million after underwriting discounts and estimated offering expenses.
Offering expected to close on or about February 2, 2024; proceeds to fund clinical pipeline development and working capital.
Jefferies acted as sole book-runner; H.C. Wainwright & Co. and Oppenheimer & Co. as lead managers.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Corbus Pharmaceuticals Holdings, Inc. entered into Underwriting Agreement with Jefferies LLC valued at approximately $88.5 million (effective 2024-01-31).

Action: entry
Agreement: underwriting
Counterparty: Jefferies LLC
Value: approximately $88.5 million
Effective: 2024-01-31

Exact text from the filing

On January 31, 2024, Corbus Pharmaceuticals Holdings, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC (the “Representative”), as representative of the several underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “Offering”) of 4,325,000 shares (the “Base Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”), at a price to the public of $19.00 per share.

View on SEC.gov

623 material agreements filed in the last 30 days. Browse all material agreements →

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-009874

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.